Chandelier
Senior Member (Voting Rights)

Long COVID More Common in Seniors: What Doctors Need to Know
Many long-COVID symptoms in people older than 65 years mimic signs of early aging, particularly cognitive, cardiac, and kidney issues.

AI Summary:
Underestimated Prevalence in Seniors
Although the CDC estimates that about 4% of long COVID patients are over the age of 65, experts believe the true number is significantly higher. Many symptoms of long COVID in seniors—such as memory loss, fatigue, or heart issues—are often misattributed to normal aging, making diagnosis difficult. As a result, many older adults may suffer from long COVID without being properly diagnosed or treated.
Challenges in Diagnosis and Medical Bias
Long COVID can worsen existing conditions like cardiovascular disease, diabetes, and dementia. However, older patients often face medical bias, with symptoms dismissed as age-related. Doctors may overlook the possibility of long COVID when presented with issues like blood clots or kidney dysfunction. This "medical gaslighting" leads to delayed or missed diagnoses, particularly in seniors who already struggle to be taken seriously in clinical settings.
To counter this, physicians are encouraged to compare a patient’s current condition to their pre-COVID health status. However, older adults are also underrepresented in clinical trials for long COVID treatments, leaving major gaps in evidence for how therapies might work in this population.
Accelerated Aging and Health Risks
Long COVID appears to speed up biological aging, particularly affecting organ systems. In older adults, this includes higher risks of kidney disease, diabetes, cardiovascular events like strokes and heart attacks, and potentially new-onset dementia. Preventative medications such as statins or ACE inhibitors may help, but further research is needed.
Early findings also indicate that COVID-related neurological symptoms could increase dementia risk, particularly among those already predisposed due to age.
Economic Consequences for Seniors
The financial burden of long COVID is especially heavy for retired individuals on fixed incomes. Many treatments that could relieve symptoms—like low-dose naltrexone, Xolair, or blood thinners—are not covered by Medicare and are often unaffordable. As a result, patients may deplete their savings and eventually rely on Medicaid.
Moreover, the rapid onset of symptoms often leaves little time for older adults to adjust their lifestyles. Unlike gradual cognitive decline, the accelerated symptoms of long COVID may force abrupt transitions to assisted living or in-home care—costs that are typically not reimbursed. Physicians may need to support patients by coordinating community resources, such as pharmacy delivery or family-assisted care.
Conclusion
Long COVID poses unique and serious risks for older adults, from underdiagnosis and medical bias to rapid health decline and financial hardship. Physicians need to approach senior care with a deeper understanding of how long COVID presents in this age group and advocate for their inclusion in research and access to affordable treatments.